These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 12969164)

  • 1. Higher participation rates for specific health checkups are associated with a lower incidence of treated ESKD in Japan.
    Wakasugi M; Narita I
    Clin Exp Nephrol; 2024 Mar; 28(3):201-207. PubMed ID: 37806975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prefecture-specific prevalence of overweight/obesity is associated with regional variation in the incidence of treated ESKD in Japan.
    Wakasugi M; Narita I
    Clin Exp Nephrol; 2023 Feb; 27(2):132-140. PubMed ID: 36209260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elucidating variations in outcomes among older end-stage renal disease patients on hemodialysis in Fukuoka Prefecture, Japan.
    Jamal A; Babazono A; Li Y; Fujita T; Yoshida S; Kim SA
    PLoS One; 2021; 16(5):e0252196. PubMed ID: 34033671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multimodality Imaging in Patients with Secondary Hypertension: With a Focus on Appropriate Imaging Approaches Depending on the Etiologies.
    Ahn H; Chun EJ; Lee HJ; Hwang SI; Choi DJ; Chae IH; Lee KW
    Korean J Radiol; 2018; 19(2):272-283. PubMed ID: 29520185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disparities in the burden, outcomes, and care of chronic kidney disease.
    Crews DC; Liu Y; Boulware LE
    Curr Opin Nephrol Hypertens; 2014 May; 23(3):298-305. PubMed ID: 24662984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with the incidence of dialysis.
    Ogata S; Nishi S; Wakai K; Iseki K; Tsubakihara Y
    Clin Exp Nephrol; 2013 Dec; 17(6):890-8. PubMed ID: 23512646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between the rate of low-birth weight newborns and the incidence of end-stage renal disease in 47 prefectures in Japan.
    Imasawa T; Nakazato T
    Clin Exp Nephrol; 2012 Aug; 16(4):617-21. PubMed ID: 22358612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low birth weight and end-stage renal disease: demographic analysis by region in Japan.
    Ichikawa T; Fukuda M; Wakamatsu-Yamanaka T; Sato R; Naito T; Togawa H; Sasakawa Y; Tomonari T; Mizuno M; Miura T; Kato Y; Ono M; Shirasawa Y; Ito A; Yoshida A; Kimura G
    Clin Exp Nephrol; 2012 Aug; 16(4):596-603. PubMed ID: 22302087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Geographic differences in the increasing ESRD rate have disappeared in Japan.
    Wakamatsu-Yamanaka T; Fukuda M; Sato R; Naito T; Togawa H; Tomonari T; Kato Y; Miura T; Mizuno M; Ichikawa T; Miyagi S; Shirasawa Y; Ito A; Yoshida A; Kimura G
    Clin Exp Nephrol; 2011 Oct; 15(5):708-713. PubMed ID: 21638004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Environmental factors influencing the survival of chronic dialysis patients.
    Ogata S; Yorioka N
    Clin Exp Nephrol; 2011 Jun; 15(3):405-409. PubMed ID: 21249416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and methods of a strategic outcome study for chronic kidney disease: Frontier of Renal Outcome Modifications in Japan.
    Yamagata K; Makino H; Akizawa T; Iseki K; Itoh S; Kimura K; Koya D; Narita I; Mitarai T; Miyazaki M; Tsubakihara Y; Watanabe T; Wada T; Sakai O;
    Clin Exp Nephrol; 2010 Apr; 14(2):144-51. PubMed ID: 20020312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Geographic difference in the prevalence of chronic kidney disease among Japanese screened subjects: Ibaraki versus Okinawa.
    Iseki K; Horio M; Imai E; Matsuo S; Yamagata K
    Clin Exp Nephrol; 2009 Feb; 13(1):44-9. PubMed ID: 18854923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Care of elderly patients with chronic kidney disease.
    Arora P; Mustafa RA; Karam J; Khalil P; Wilding G; Ranjan R; Lohr J
    Int Urol Nephrol; 2006; 38(2):363-70. PubMed ID: 16868713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maps of end-stage renal disease and amounts of angiotensin-converting enzyme inhibitors prescribed in Japan.
    Usami T; Nakao N; Fukuda M; Takeuchi O; Kamiya Y; Yoshida A; Kimura G
    Kidney Int; 2003 Oct; 64(4):1445-9. PubMed ID: 12969164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated therapies including erythropoietin decrease the incidence of dialysis: lessons from mapping the incidence of end-stage renal disease in Japan.
    Furumatsu Y; Nagasawa Y; Hamano T; Iwatani H; Iio K; Shoji T; Ito T; Tsubakihara Y; Imai E
    Nephrol Dial Transplant; 2008 Mar; 23(3):984-90. PubMed ID: 17956890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional differences in end-stage renal disease and amount of protein intake in Japan.
    Motokawa M; Fukuda M; Muramatsu W; Sengo K; Kato N; Usami T; Yoshida A; Kimura G
    J Ren Nutr; 2007 Mar; 17(2):118-25. PubMed ID: 17321951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proposal for mapping renal failure in Japan and its application for strategy to arrest endstage renal disease.
    Usami T; Kimura G
    Clin Exp Nephrol; 2006 Mar; 10(1):8-12. PubMed ID: 16544172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different regional dynamics of end-stage renal disease in Japan by different causes.
    Kato N; Usami T; Fukuda M; Motokawa M; Kamiya Y; Yoshida A; Kimura G
    Nephrology (Carlton); 2005 Aug; 10(4):400-4. PubMed ID: 16109089
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.